NUVISION BIOTHERAPIES LIMITED

Active

Registry details

Reference data exactly as held at Companies House.

Copy registry details
Registered office
Medicity, D6 Building, Thane Road, Nottingham NG90 6BH
Accounts type
Total Exemption Full

Company activity

The 4 most recent documents filed at Companies House.

Pre-Score for UK companies is coming soon
  1. 19/06/2026

    Appointment of Mr Timothy James Precious as a director on 2026-05-26

    View PDF (2 pages)
  2. 14/04/2026

    Appointment of Mr Noel Waters as a director on 2025-06-19

    View PDF (2 pages)
  3. 14/04/2026

    Termination of appointment of Noel Waters as a director on 2025-06-19

    View PDF (1 pages)
  4. 14/04/2026

    Confirmation statement made on 2026-02-11 with updates

    View PDF (13 pages)

Accounts and confirmation statement

The two filings Companies House requires every year, and where each one stands against its deadline today.

Annual accounts

Total Exemption Full accounts

On schedule

31/03/2027Filing deadline

Next accounts made up to
30/06/2026
Last accounts made up to
30/06/2025

Confirmation statement

Confirms the registry record is up to date

On schedule

25/02/2027Filing deadline

Next statement date
11/02/2027
Last statement dated
11/02/2026

See the full filing history

Financial performance

The latest figures NUVISION BIOTHERAPIES LIMITED filed. Okredo holds filed accounts data for 2021–2025; the year-by-year record is on the financials page.

Net Assets

£1.08M2025
708.94%vs 2024

2024: £-177.05K

Total Assets

£1.47M2025
228.37%vs 2024

2024: £446.41K

Cash in Bank

£928.80K2025
2.00K%vs 2024

2024: £44.29K

Total Liabilities

£360.45K2025
-40.72%vs 2024

2024: £608.02K

Employees

262025
+5vs 2024

2024: 21

Of the 4 measures with an earlier filing to compare against, 3 rose and 1 fell. Net assets moved furthest, up 708.94% on 2024. See the full financial analysis for NUVISION BIOTHERAPIES LIMITED.

Employees

Headcount as reported to Companies House for 2021–2025.

132021
142022
182023
212024
262025
YearEmployeesChange
202526+5
202421+3
202318+4
202214+1
202113–

Reported employee count increased from 13 in 2021 to 26 in 2025. See how headcount moved alongside the reported financials.

Credit report

It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.

Officers

18

Directors, secretaries and other appointed officers, with the period each has served.

PersonRolePeriodConnected companies
Corporate Director26/11/2020–Present153
Director19/01/2018–31/03/202618
Director07/04/2015–20/05/201548
Director01/03/2018–Present29
Director26/05/2026–Present12
Director08/07/2015–16/10/20178
Director20/05/2015–Present1
Director08/07/2015–14/12/20150
Director08/07/2015–14/12/20151
Director19/12/2019–28/04/20210
Director20/05/2015–31/05/20182
Corporate Director08/07/2015–24/05/20190
Director17/09/2020–19/05/20226
Director20/01/2022–31/12/202515
Director08/07/2015–31/03/201810
Director24/05/2019–26/11/20205
Director19/06/2025–19/06/20250
Director19/06/2025–Present19

Filing history and recent activity

Every document on the Companies House record, newest first.

Filings on record
28
Since 13/01/2023
Last 12 months
7
+1 vs the year before
Most recent filing
19/06/2026
3 months ago

What changed in the last year

  • Officer changes (5)Latest 19/06/2026
  • Confirmation statementLatest 14/04/2026
  • Accounts filedLatest 09/03/2026

Filing timeline

  1. 19/06/2026

    Appointment of Mr Timothy James Precious as a director on 2026-05-26

    View PDF (2 pages)
  2. 14/04/2026

    Appointment of Mr Noel Waters as a director on 2025-06-19

    View PDF (2 pages)
  3. 14/04/2026

    Termination of appointment of Noel Waters as a director on 2025-06-19

    View PDF (1 pages)
  4. 14/04/2026

    Confirmation statement made on 2026-02-11 with updates

    View PDF (13 pages)
  5. 07/04/2026

    Termination of appointment of Jonathan Mark Treherne as a director on 2026-03-31

    View PDF (1 pages)
  6. 09/03/2026

    Total exemption full accounts made up to 2025-06-30

    View PDF (9 pages)
  7. 01/01/2026

    Termination of appointment of Andrew Hill as a director on 2025-12-31

    View PDF (1 pages)
  8. 24/06/2025

    Appointment of Mr Noel Waters as a director on 2025-06-19

    View PDF (2 pages)
  9. 24/06/2025

    Appointment of Mr Timothy John Gray as a director on 2025-06-19

    View PDF (2 pages)
  10. 15/04/2025

    Statement of capital following an allotment of shares on 2025-03-25

    View PDF (5 pages)
  11. 11/02/2025

    Confirmation statement made on 2025-02-11 with updates

    View PDF (12 pages)
  12. 07/02/2025

    Total exemption full accounts made up to 2024-06-30

    View PDF (10 pages)

Showing 12 of 28 filings

See when the next accounts and confirmation statement are due

Similar companies

6 UK companies are similar to NUVISION BIOTHERAPIES LIMITED, sharing the same company status (Active), the same industry sector and activity group (Manufacture of pharmaceutical preparations) and a comparable number of employees. The 5 closest matches are shown below to help you compare competitors and industry peers.

6 UK companies share this business profileThe 5 above are the closest matches. See every UK company registered under Manufacture of pharmaceutical preparations.Browse the listing

About NUVISION BIOTHERAPIES LIMITED

A short description of the company, written from its Companies House record.

NUVISION BIOTHERAPIES LIMITED is a private limited company registered in the United Kingdom, based in Medicity, D6 Building, Thane Road, Nottingham NG90 6BH. Companies House classifies its business as Manufacture of pharmaceutical preparations. It has been on the register for 11 years 5 months.

The register currently records it as active. Its 2025 accounts report net assets of £1.08M and 26 employees.

NUVISION BIOTHERAPIES LIMITED: frequently asked questions

Answered from this company's own registry record and filed figures.

Companies House records NUVISION BIOTHERAPIES LIMITED under one registered business activity: Manufacture of pharmaceutical preparations (21.20 - SIC 2007).

NUVISION BIOTHERAPIES LIMITED is recorded as active on the Companies House register, and has been on it since 07/04/2015.

The most recent accounts Okredo holds cover 2025 and report net assets of £1.08M, total assets of £1.47M, cash in bank of £928.80K and total liabilities of £360.45K.

The most recent document on the record is dated 19/06/2026: Appointment of Mr Timothy James Precious as a director on 2026-05-26, 3 months ago.

On the current registry record, accounts are due by 31/03/2027 and the next confirmation statement is due by 25/02/2027.

Companies House lists 18 officers (5 currently in post) and 0 people with significant control.